Frazier Life Sciences Management, L.P. Evolus, Inc. Transaction History
Frazier Life Sciences Management, L.P.
- $2.36 Billion
- Q3 2025
A detailed history of Frazier Life Sciences Management, L.P. transactions in Evolus, Inc. stock. As of the latest transaction made, Frazier Life Sciences Management, L.P. holds 2,630,665 shares of EOLS stock, worth $19 Million. This represents 0.68% of its overall portfolio holdings.
Number of Shares
2,630,665
Previous 2,435,550
8.01%
Holding current value
$19 Million
Previous $22.4 Million
27.99%
% of portfolio
0.68%
Previous 1.18%
Shares
2 transactions
Others Institutions Holding EOLS
# of Institutions
172Shares Held
50.5MCall Options Held
175KPut Options Held
539K-
Nantahala Capital Management, LLC New Canaan, CT5.73MShares$41.3 Million1.43% of portfolio
-
Tang Capital Management LLC San Diego, CA5.49MShares$39.6 Million1.53% of portfolio
-
Black Rock Inc. New York, NY4.01MShares$28.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.43MShares$24.8 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.86MShares$13.4 Million0.01% of portfolio
About Evolus, Inc.
- Ticker EOLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 56,094,800
- Market Cap $405M
- Description
- Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...